130 related articles for article (PubMed ID: 3474327)
1. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
Nagler A; Rikilis I; Tatarsky I; Fabian I
J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns.
Nagler A; Riklis I; Kletter Y; Tatarsky I; Fabian I
Exp Hematol; 1986 Jan; 14(1):60-5. PubMed ID: 3510890
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of bone marrow cells from myelodysplastic patients in the presence of 1,25 dihydroxyvitamin D3 or 13-cis retinoic acid.
Nagler A; Ricklis I; Gazit E; Tatarsky I; Fabian I
Eur J Clin Invest; 1986 Aug; 16(4):297-301. PubMed ID: 3093242
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]].
Irino S; Taoka T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981
[TBL] [Abstract][Full Text] [Related]
6. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
[TBL] [Abstract][Full Text] [Related]
7. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 and the regulation of the differentiation and function of macrophages and granulocytes.
Shezen E; Goldman R
Int J Cell Cloning; 1985 Mar; 3(2):65-80. PubMed ID: 3839007
[TBL] [Abstract][Full Text] [Related]
9. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
10. In vitro hemopoiesis of marrow cells from myelodysplastic patients: effects of mitogen-stimulated spleen cell-conditioned medium and vitamin A and D derivatives.
Fabian I; Riklis I; Tatarsky I; Nagler A
Cancer Res; 1986 May; 46(5):2596-9. PubMed ID: 3697999
[TBL] [Abstract][Full Text] [Related]
11. 1 alpha, 25-Dihydroxyvitamin D3 augments clonal growth of macrophages from rat bone marrow progenitor cells and modulates their function.
Shezen E; Goldman R
Int J Cell Cloning; 1986 Mar; 4(2):115-25. PubMed ID: 3754272
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 induces normal mononuclear blood cells to differentiate in the direction of monocyte-macrophages.
Choudhuri U; Adams JA; Byrom N; McCarthy DM; Barrett J
Haematologia (Budap); 1990; 23(1):9-19. PubMed ID: 2397925
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of human myeloid leukemia cell line ML-1 induced by retinoic acid and 1,25-dihydroxyvitamin D3.
Haskovec C; Lemez P; Neuwirtová R; Wilhelm J; Jarolím P
Neoplasma; 1990; 37(5):565-72. PubMed ID: 1700313
[TBL] [Abstract][Full Text] [Related]
14. Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes.
Swanson G; Picozzi V; Morgan R; Hecht F; Greenberg P
Blood; 1986 Apr; 67(4):1154-61. PubMed ID: 3513868
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures.
Dorshkind K; Reichel H; Norman AW
Exp Hematol; 1989 Jun; 17(5):436-42. PubMed ID: 2785458
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytosine arabinoside on differentiation of normal human bone marrow cells.
Nagler A; Kletter Y; Ricklis I; Gazit E; Tatarsky I; Fabian I
Exp Hematol; 1986 Mar; 14(3):241-5. PubMed ID: 2419152
[TBL] [Abstract][Full Text] [Related]
17. The effect of low dose ARA-C on in-vitro haemopoiesis of marrow cells from myelodysplastic patients.
Nagler A; Riklis I; Tatarsky I; Fabian I
Leuk Res; 1987; 11(4):379-84. PubMed ID: 3561019
[TBL] [Abstract][Full Text] [Related]
18. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
19. Myeloid differentiation in liquid cultures of cells from patients with chronic myeloid leukemia: effects of retinoic acid and indomethacin.
Nilsson B; Olofsson T; Olsson I
Exp Hematol; 1984 Feb; 12(2):91-9. PubMed ID: 6583069
[TBL] [Abstract][Full Text] [Related]
20. The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro.
McCarthy D; Hibbin J; San Miguel JF; Freake H; Rodrigues B; Andrews C; Pinching A; Catovsky D; Goldman JM
Int J Cell Cloning; 1984 Jul; 2(4):227-42. PubMed ID: 6086776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
